Inhibiting NLRP3 inflammasome activity in acute myocardial infarction: a review of pharmacologic agents and clinical outcomes

LF Buckley, P Libby - Journal of Cardiovascular Pharmacology, 2019 - journals.lww.com
The NLRP3 inflammasome is an intracellular, multimeric protein complex that initiates a
potent inflammatory response to danger signals. After acute myocardial infarction, NLRP3 …

Cell-specific roles of NLRP3 inflammasome in myocardial infarction

M Takahashi - Journal of Cardiovascular Pharmacology, 2019 - journals.lww.com
An accumulating body of evidence indicates that NLRP3 inflammasome plays a crucial role
in the pathophysiology of cardiovascular diseases, including atherosclerosis and acute …

NLRP3 inflammasome in cardioprotective signaling

CJ Zuurbier - Journal of Cardiovascular Pharmacology, 2019 - journals.lww.com
The NLRP3 inflammasome may contribute to infarct development during acute cardiac
ischemia-reperfusion (IR). Because infarct size strongly correlates with the degree of heart …

Role of NLRP3 inflammasome in cardiac inflammation and remodeling after myocardial infarction

M Takahashi - Biological and Pharmaceutical Bulletin, 2019 - jstage.jst.go.jp
An accumulating body of evidence indicates that inflammation plays a crucial role in the
pathophysiology of myocardial infarction (MI). Nucleotide-binding oligomerization domain …

[HTML][HTML] The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the …

S Toldo, AG Mauro, Z Cutter… - Journal of …, 2019 - journals.lww.com
Background: Activation of the NLRP3 inflammasome is a primary driver of sterile
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …

NLRP3 inflammasome in acute myocardial infarction

AG Mauro, A Bonaventura, E Mezzaroma… - Journal of …, 2019 - journals.lww.com
Acute myocardial infarction (AMI) is associated with the induction of a sterile inflammatory
response that leads to further injury. The NACHT, leucine-rich repeat, and pyrin domain …

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

GPJ Van Hout, L Bosch, GHJM Ellenbroek… - European heart …, 2017 - academic.oup.com
Aims Myocardial infarction (MI) triggers an intense inflammatory response that is associated
with infarct expansion and is detrimental for cardiac function. Interleukin (IL)-1β and IL-18 …

[HTML][HTML] Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction

MJM Silvis, EJ Demkes, ATL Fiolet, M Dekker… - Journal of …, 2021 - Springer
Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity
worldwide. Atherosclerosis is responsible for the majority of cardiovascular disorders with …

The NLRP3 inflammasome in acute myocardial infarction

S Toldo, A Abbate - Nature Reviews Cardiology, 2018 - nature.com
The heart is extremely sensitive to ischaemic injury. During an acute myocardial infarction
(AMI) event, the injury is initially caused by reduced blood supply to the tissues, which is …

Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases

D Liu, X Zeng, X Li, JL Mehta, X Wang - Basic research in cardiology, 2018 - Springer
NLRP3 inflammasome is a key multiprotein signaling platform that tightly controls
inflammatory responses and coordinates antimicrobial host defenses by activating caspase …